Can-Fite BioPharma
TASE:CANF
4,84
₪-0,03 (-0,62%)
4,84
₪-0,03 (-0,62%)
End-of-day quote: 04/10/2026

Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.

G
-36,62%
5-year Growth Rate
R
2/5
5-year Risk Analysis
O
38020%
Outlook 12/25
W
51,54%
Margin of safety
T
N/A
Analyst Price Target
H
UP
50-week EMA Trend

Company Info

EPS Growth 5Y
-169,82%
Revenue growth 5Y
189,70%
Price growth 5Y
1692,59%
Market Cap
₪0,02 B
Long-Term Debt
₪0,00 B
Quarterly earnings
05/28/2026 (E)
Dividend
₪0,00
Dividend Yield
0,00%
Industry
Country
ISIN Number

Can-Fite BioPharma Price Chart

1M 3M YTD 1Y 2Y 5Y 10Y 20Y

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

There are currently no price targets available for this stock.

Top growth stocks in the health care sector

Stock Rate of Return 5Y Price 5Y Div. 5Y G R O W T H
Can-Fite BioPharma
TASE:CANF
1692,59% 1692,59% 0,00% -36,62% 2/5 38020,47% 51,54% -100,00% UP
×